Cambrex Industry Insights

1. Fewer Setbacks, Faster To IND 7/25/2026

   Cy Credille, Group Leader in process chemistry at Cambrex Longmont, on the setbacks that come as standard in early development — and why a team that has seen them all before is the fastest route to the IND finish line.

2. Ask Us Anything: Eric Fang On Lithiation Chemistry 7/24/2026

   Eric Fang, General Manager of Snapdragon Chemistry, on why lithiation chemistry resists batch scale-up — and how a decade spent understanding static mixing lets Snapdragon carry these reactions from milligrams to metric tons.

3. Solutions For Overcoming New Challenges In Pharmaceutical Development 7/24/2026

   Eric Fang on meeting new pharmaceutical development challenges with a two-part investment — technology that answers R&D questions faster, and scientists given the support to tackle what technology can't.

4. Revolutionizing The Development, Characterization, And Manufacturing Of Peptides 7/24/2026

   Erik Feldmann, Technical Director, on the analytical challenges of proteins, peptides, and oligonucleotides — and why he starts every method-development problem by understanding what the customer is trying to achieve.

5. How Is Peptide Crystallization Screening Used In Peptide-Based Therapeutic Development? 7/24/2026

   Hannah McLachlan, Project Scientist IV at Cambrex Edinburgh, on what crystallization screening delivers for peptide therapeutics — more stable material, higher purity, and a molecule clients can store without specialist infrastructure.

6. Emerging Technologies In Reactor Design 7/23/2026

   Jillian Sheeran, Associate Director of Engineering at Snapdragon Chemistry, on how automation, feedback control, and machine learning are changing reactor design — with real-time monitoring that lets a process run continuously while the data comes to you.

7. How Solid-State Characterization Shapes Drug Development 7/23/2026

   Mark Benger, Site Director at Cambrex Edinburgh, on solid-state characterization as an insurance policy — front-loaded work that quietly determines whether a program survives the jump from kilos to tonnes.

8. How Biocatalysts Address Process Development Issues 7/23/2026

   Antje Gupta, General Manager of Cambrex IEP in Wiesbaden, on where biocatalysis outperforms conventional chemistry — matching enzyme classes to target conversions and production volumes to find the more scalable, more economical route.

9. Optimizing Yield, Purity, And Scalability In A Cost-Effective Manner During Process Development 7/23/2026

   Daniele Vigo, Assistant Director at Cambrex Milan, on getting yield, purity, and scalability right without burning through the budget.

10. How AI And Automation Are Impacting Process Development 7/23/2026

    David Ford, Senior Director of Chemistry at Snapdragon Chemistry, on the mountain of data behind every process development program — and why AI's real promise is surfacing the right piece of it at the moment a team needs to decide.